MRI and cognition: markers associated with cognitive impairment in small vessel disease

What the researchers studied

The review focuses on white matter hyperintensities, a feature visible on MRI in cerebral small vessel disease. The aim was to examine their associations with cognitive performance using conventional and advanced imaging techniques.

The researchers searched four bibliographic databases and included 15 studies involving 5,752 participants. The adults included had markers of this disease on MRI and had undergone a standardized cognitive assessment. The findings were synthesized narratively, by imaging technique, rather than as an overall statistical estimate.

An association particularly evident for processing speed

In studies using conventional MRI, a greater burden of hyperintensities and more severe disease were associated with poorer cognitive performance. Information processing speed and global cognition stood out in particular.

Advanced techniques also found associations between cognitive performance and microstructural or microvascular white matter abnormalities. Reduced blood flow was also associated with poorer cognitive results. These observations alone do not demonstrate a cause-and-effect relationship.

What these findings change—and what they do not

This synthesis reinforces the value of studying multiple dimensions of MRI to understand cognitive impairment in small vessel disease. However, it does not establish that any given marker can reliably predict how a person's cognition will change.

The abstract reports encouraging predictive or diagnostic performance in some individual studies. These findings do not amount to validation across all the studies. The authors call for larger, standardized studies to determine the value of these markers for early detection and monitoring.

An assessment limited to the abstract

The dossier provides access to the PubMed abstract, not the full text. It therefore does not allow a detailed examination of risks of bias, follow-up durations or differences between populations. Funding and conflicts of interest have not been verified.

The participants already had markers of small vessel disease. These findings cannot be applied without qualification to healthy adults or, on their own, justify MRI screening.

What we can take away

White matter abnormalities on MRI are associated with cognition in small vessel disease. Their usefulness for early detection or monitoring of cognitive impairment remains to be validated.